Literature DB >> 11254795

Medical management of stroke.

K W Muir1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11254795      PMCID： PMC1765553          DOI： 10.1136/jnnp.70.suppl_1.i12

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group.

Authors:  P M Rothwell; C P Warlow
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

2.  Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.

Authors:  Z M Chen; P Sandercock; H C Pan; C Counsell; R Collins; L S Liu; J X Xie; C Warlow; R Peto
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

3.  Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important?

Authors:  B Indredavik; F Bakke; S A Slordahl; R Rokseth; L L Hâheim
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

4.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

5.  Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.

Authors:  K R Lees; K Asplund; A Carolei; S M Davis; H C Diener; M Kaste; J M Orgogozo; J Whitehead
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

6.  Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.

Authors:  D G Sherman; R P Atkinson; T Chippendale; K A Levin; K Ng; N Futrell; C Y Hsu; D E Levy
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

7.  Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.

Authors:  P M Bath; R Iddenden; F J Bath
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

8.  Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

Authors:  S F de Bruijn; J Stam
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

9.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.